Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02259049 · ClinicalTrials.gov registry record · Early Phase 1
The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease
A Early Phase 1 study of Blood Pressure, sponsored by New York Institute of Technology.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02259049: Completed Early Phase 1 study of Blood Pressure, sponsored by New York Institute of Technology.
NCT02259049 is a Early Phase 1 study of Blood Pressure that has completed, run by New York Institute of Technology. The registered enrollment target is 6 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02259049, a Early Phase 1 study of Blood Pressure, has completed, sponsored by New York Institute of Technology.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are observing the effects 2,000 mg of L-tyrosine will have on 24 hour blood pressure fluctuations in individuals with Parkinson's disease.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Sugar Pill
- DIETARY_SUPPLEMENT L-tyrosine
Study Locations (1)
New York
- New York Institute of Technology - Old Westbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-09 |
| Phase | Early Phase 1 |
What the finished NCT02259049 record still lists
NCT02259049 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Sugar Pill is the first listed.
NCT02259049 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02259049 about?
NCT02259049 is a clinical study titled "The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease". The investigators are observing the effects 2,000 mg of L-tyrosine will have on 24 hour blood pressure fluctuations in individuals with Parkinson's disease.
What is the current status of trial NCT02259049?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2014-10. Estimated completion is 2015-09.
What conditions does trial NCT02259049 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT02259049?
The interventions under investigation include: Sugar Pill (DIETARY_SUPPLEMENT), L-tyrosine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02259049?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02259049 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02259049's enrollment target sits among peer trials
6 101st of 101 higher than 1 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Autonomic Control of the Circulation and VDR
RECRUITING · Early Phase 1
-
Reversing Glucose and Lipid-mediated Vascular Dysfunction
RECRUITING · Early Phase 1
-
Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia
RECRUITING · Early Phase 1
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia